KLRC1 and neoplasm: Taken together, our results demonstrated that αNKG2A-N215 may orchestrate both T and NK cells by using αNKG2A to brake off the immune check of NKG2A as well as by using N215 to trigger IL2-Rβγ, which reversed the tumor-induced T and NK cell exhaustion thus enhanced the antitumor immune responses.